Found 51 matching trials
Evaluation of Treatment by Glofitamab in Combination With Rituximab or Obinutuzumab Plus CHOP in Patients With RIchter Syndrome PHASE2 This is a national clinical trial, multicentric (28 centers), non-randomize...
Show More Location
Amiens-Picardie Chu
Learn More & Join Trial
Cinobufacini Tablets Combined With Chemotherapeutic Protocol in Treatment of Diffuse Large B Cell Lymphoma PHASE2 Diffuse large B cell lymphoma (DLBCL), as the most common subtype non-Hodgk...
Show More Location
Cancer Hospital Affiliated to Xinjiang Medical University
Learn More & Join Trial
Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCL PHASE1 Diffuse large B-cell lymphoma is a most prevalent non-Hodgkin's lymphoma. R...
Show More Location
Asan Medical Center, University of Ulsan College of Medicine
Learn More & Join Trial
Alemtuzumab and CHOP in T-cell Lymphoma PHASE3 The purpose of this study is to determine efficacy and safety of the monocl...
Show More Learn More & Join Trial
Orelabrutinib Combined With Induction Therapy Followed by Sequential Monotherapy Maintenance in MCD Subtype Diffuse Large B-cell Lymphoma PHASE2 This is a single-center, single-arm, prospective study aimed at evaluating ...
Show More Location
The First Bethune Hospital of Jilin University
Learn More & Join Trial
A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma PHASE2 Study of ONTAK and CHOP (chemotherapy drugs) to find out their ability to m...
Show More Location
Birmingham Hematology and Oncology
Learn More & Join Trial
Obinutuzumab in Chinese Real-world Patients With iNHL N/A This study aims to assess the clinical efficacy and safety of obinutuzumab ...
Show More Location
Changzhou No.2 People's Hospital
Learn More & Join Trial
Shortened vs Standard Chemotherapy Combined With Immunotherapy for the Initial Treatment of Patients With High Tumor Burden Follicular Lymphoma PHASE3 FIL\_FOLL19 is an open-label, multicenter, randomized phase III trial. The ...
Show More Status
Active Not Recruiting
Location
IRCCS Istituto Romagnolo per lo studio dei Tumori "Dino Amadori" - IRST S.R.L. - Ematologia
Learn More & Join Trial
Study of Rituximab-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkin's Lymphomas in Patients 60 Years Old or Younger PHASE2 The overall goal of this clinical research study was to find out which of t...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Analysis of the Risk Factors for the Neutropenic Fever in the High Risk NHL Patients for Developing Febrile Neutropenia Who Received 3-weekly CHOP-like Chemotherapy With Primary G-CSF Prophylaxis; Prospective Multicenter Observation Study N/A The domestic standards of G-CSF permit the use of the G-CSF only when the A...
Show More Location
Severance Hospital
Learn More & Join Trial